AZN — AstraZeneca Share Price

As of Today at 10:23 UTC, shares in AstraZeneca are trading at 10,450.00p. This share price information is delayed by 15 minutes.

Shares in AstraZeneca last closed at 10,450.00p and the price had moved by -13.64% over the past 365 days. In terms of relative price strength the AstraZeneca share price has underperformed the FTSE All Share Index by -19.59% over the past year.

The overall consensus recommendation for AstraZeneca is Buy. You can view the full broker recommendation list by unlocking its StockReport.

The AstraZeneca dividend yield is 2.19% based on the trailing twelve month period.

Last year, AstraZeneca paid a total dividend of $3.08, and it currently has a trailing dividend yield of 2.19%. We do not have any data on when AstraZeneca is to next pay dividends.

We do not have data on when AstraZeneca is to next pay dividends.  The historic dividend yield on AstraZeneca shares is currently 2.19%.

To buy shares in AstraZeneca you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of 10,450.00p, shares in AstraZeneca had a market capitalisation of £162.05bn.

Here are the trading details for AstraZeneca: 

• Country of listing: United Kingdom
• Exchange: LSE
• Ticker Symbol: AZN

Based on an overall assessment of its quality, value and momentum AstraZeneca is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

The analyst consensus target price for shares in AstraZeneca is 13,299.50p.  That is 27.27% above the last closing price of 10,450.00p.

Analysts covering AstraZeneca currently have a consensus Earnings Per Share (EPS) forecast of $9.00 for the next financial year.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like AstraZeneca. Over the past six months, its share price has underperformed the FTSE All Share Index by -12.55%.

As of the last closing price of 10,450.00p, shares in AstraZeneca were trading -4.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The AstraZeneca PE ratio based on its reported earnings over the past 12 months is 14.63. The shares last closed at 10,450.00p. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

AstraZeneca's management team is headed by: 

• Leif Johansson - NEC
• Pascal Soriot - CEO
• Aradhana Sarin - CFO
• Jeffrey Pott - CHO
• Katarina Ageborg - EVP
• Jose Baselga - EVP
• Pam Cheng - EVP
• Ruud Dobber - EVP
• David Fredrickson - EVP
• Menelas Pangalos - EVP
• Iskra Reic - EVP
• Leon Wang - EVP
• Adrian Kemp - SEC
• Euan Ashley - NED
• Diana Layfield - NED
• Tony Mok - NED
• Andreas Rummelt - NED
• Marcus Wallenberg - NED
• Philip Broadley - NID
• Michel Demare - NID
• Deborah Eldracher - NID
• Sherilyn McCoy - NID
• Nazneen Rahman - NID